An insight on medicinal attributes of 1, 2, 4-triazoles

R Aggarwal, G Sumran - European journal of medicinal chemistry, 2020 - Elsevier
The present review aims to summarize the pharmacological profile of 1, 2, 4-triazole, one of
the emerging privileged scaffold, as antifungal, antibacterial, anticancer, anticonvulsant …

Novel approaches, drug candidates, and targets in pain drug discovery

S Obeng, T Hiranita, F León, LR McMahon… - Journal of medicinal …, 2021 - ACS Publications
Because of the problems associated with opioids, drug discovery efforts have been
employed to develop opioids with reduced side effects using approaches such as biased …

[HTML][HTML] Cyclooxygenase-2 (COX-2) as a target of anticancer agents: A review of novel synthesized scaffolds having anticancer and COX-2 inhibitory potentialities

NUA Mohsin, S Aslam, M Ahmad, M Irfan… - Pharmaceuticals, 2022 - mdpi.com
Cancer is a serious threat to human beings and is the second-largest cause of death all over
the globe. Chemotherapy is one of the most common treatments for cancer; however, drug …

1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies

M Hagras, MA Saleh, RR Ezz Eldin… - Journal of enzyme …, 2022 - Taylor & Francis
In the current work, some 1, 3, 4-oxadiazole-naphthalene hybrids were designed and
synthesised as VEGFR-2 inhibitors. The synthesised compounds were evaluated in vitro for …

Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)

SMI Mahboubi Rabbani, A Zarghi - Expert opinion on therapeutic …, 2019 - Taylor & Francis
Introduction: COX-2 is a key enzyme in the process of prostaglandins (PGs) synthesis. The
products of this enzyme could play a major role as the mediators of the inflammatory …

Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2, 4-dione derivatives: histone deacetylases inhibitory activity and molecular …

A Hamdi, WM Elhusseiny, DIA Othman, A Haikal… - European Journal of …, 2022 - Elsevier
The antitumor activity of the newly synthesized 5-arylidenethiazolidine-2, 4-dione derivatives
18a–f and 19a–f was investigated, compared to doxorubicin (IC 50= 4.17–8.87 μM) and …

Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective

S Chahal, P Rani, Kiran, J Sindhu, G Joshi… - ACS …, 2023 - ACS Publications
Innate inflammation beyond a threshold is a significant problem involved in cardiovascular
diseases, cancer, and many other chronic conditions. Cyclooxygenase (COX) enzymes are …

Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR …

HM Alkahtani, AN Abdalla, AJ Obaidullah… - Bioorganic …, 2020 - Elsevier
We synthesized a new series of 2-[(3-(4-sulfamoylphenethyl)-4 (3H)-quinazolinon-2-yl) thio]
anilide derivatives (2–16) and evaluated their cytotoxic activity against breast …

Design, synthesis, and antitumor activity of novel compounds based on 1, 2, 4-triazolophthalazine scaffold: apoptosis-inductive and PCAF-inhibitory effects

A Turky, AH Bayoumi, A Ghiaty, AS El-Azab… - Bioorganic …, 2020 - Elsevier
The antitumor activity of newly synthesised triazolophthalazines (L-45 analogues) 10–32
was evaluated in human hepatocellular carcinoma (HePG-2), breast cancer (MCF-7) …

[HTML][HTML] Synthesis and investigation of anti-inflammatory activity of new thiourea derivatives of naproxen

N Nedeljković, V Dobričić, J Bošković, M Vesović… - Pharmaceuticals, 2023 - mdpi.com
The aim of the study was a synthesis and investigation of the dose-dependent anti-
inflammatory effect of new thiourea derivatives of naproxen with selected aromatic amines …